Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination (Q26700080)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination |
scientific article |
Statements
7 references
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination (English)
0 references
3 May 2016
7 references
20 June 2019
25 June 2019
3 November 2019
5 August 2020
22 November 2020
9 April 2021
23 October 2022
8 references
20 June 2019
25 June 2019
3 November 2019
5 August 2020
22 November 2020
9 April 2021
23 October 2022
12
0 references
5
0 references
1102-16
0 references
7 references
20 June 2019
25 June 2019
3 November 2019
5 August 2020
22 November 2020
9 April 2021
23 October 2022
2 references
2 references
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference